Todd M. Cooper

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2016 · 597 citations · Full text

The genomic landscape of juvenile myelomonocytic leukemia

Elliot Stieglitz, Amaro Taylor‐Weiner, Tiffany Chang et al. · Nature Genetics · 2015 · 305 citations · Full text

Hematological Malignancy, Chromatin, Genomic Landscape +7

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

Michael R. Loken, Todd A. Alonzo, Laura Pardo et al. · Blood · 2012 · 291 citations · Full text

Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy

Rebecca Gardner, Francesco Ceppi, Julie Rivers et al. · Blood · 2019 · 279 citations · Full text

AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia

Todd M. Cooper, Janet Franklin, Robert B. Gerbing et al. · Cancer · 2011 · 192 citations · Full text